Research Grant[Cite as http://purl.org/au-research/grants/nhmrc/1089138]
Researchers: A/Pr Kelli Macdonald (Principal investigator)
Brief description Hematopoietic stem cell transplantation (SCT) is the only curative therapy for most blood cancers. The curative property of SCT relates to the graft-versus-leukaemia effect, which eradicates any remaining cancer after SCT. Unfortunately the success of SCT is significantly limited by three procedural complications: GVHD, graft failure, and infection. Our research aims to improve our understanding how these complications arise to develop new therapies that can be translated to clinical practice.
Funding Amount $AUD 956,055.65
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1089138
- nhmrc : 1089138